It seems to be in early stage to develop therapies for patients with heart failure using wireless cardiac stimulation. Based on the website it seems to be based in US. Not sure why they want to list in Australia then. Bell Porter is leading and there is presentation at 12.30 pm today. Bell Porter is not sharing any information to sophisticated investors as well. @Lefevre what is your view on this company? Given you are the expert in this sector.
